Tell the surgical or anaesthetic team exactly what you take and when your last dose was
Here, we will review the evidence for SGLT2i and GLP1-RA in lupus
In SURMOUNT-5 head-to-head, tirzepatide 15 mg produced -20.2% weight loss vs -13.7% for semaglutide 2.4 mg at 72 weeks
At 24 mg, the majority of participants achieved clinically meaningful weight loss thresholds, and by week 48, 95.7% of individuals treated with CT-388 lost a minimum of 5% of body weight, while 87% achieved reductions of at least 10%
Microglia activated by excessive glutamate levels can secrete various cytokines, which facilitate glutamate release presumably through xc() on microglia, and suppress the uptake of glutamate through EAATs on astrocytes [71, 88, 89]
BPC 157 has been demonstrated to be an efficient therapy of inflammatory bowel disease